UPDATE: JPMorgan Upgrades Infinity Pharmaceutical (INFI) to Overweight
Tweet Send to a Friend
(Updated - August 2, 2021 4:18 AM EDT)
JPMorgan analyst Anupam Rama upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
JPMorgan analyst Anupam Rama upgraded Infinity Pharmaceutical (NASDAQ: INFI) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE